Enhanced cellular immune response against SIV Gag induced by immunization with DNA vaccines expressing assembly and release-defective SIV Gag proteins
- PMID: 12758174
- DOI: 10.1016/s0042-6822(03)00066-7
Enhanced cellular immune response against SIV Gag induced by immunization with DNA vaccines expressing assembly and release-defective SIV Gag proteins
Abstract
Codon-optimized genes were synthesized for the SIVmac239 Gag, a mutant Gag with mutations in the major homology region, and a chimeric Gag containing a protein destruction signal at the N-terminus of Gag. The mutant and chimeric Gag were expressed at levels comparable to that observed for the wild-type Gag protein but their stability and release into the medium were found to be significantly reduced. Immunization of mice with DNA vectors encoding the mutant or chimeric Gag induced fourfold higher levels of anti-SIV Gag CD4 T cell responses than the DNA vector encoding the wild-type SIV Gag. Moreover, anti-SIV Gag CD8 T cell responses induced by DNA vectors encoding the mutant or chimeric Gag were found to be 5- to 10-fold higher than those induced by the DNA construct for the wild-type Gag. These results indicate that mutations disrupting assembly and/or stability of the SIV Gag protein effectively enhance its immunogenicity when expressed from DNA vaccines.
Similar articles
-
Enhanced immunogenicity of SIV Gag DNA vaccines encoding chimeric proteins containing a C-terminal segment of Listeriolysin O.Virus Res. 2003 Nov;97(1):7-16. doi: 10.1016/s0168-1702(03)00216-8. Virus Res. 2003. PMID: 14550583
-
Containment of simian immunodeficiency virus infection in vaccinated macaques: correlation with the magnitude of virus-specific pre- and postchallenge CD4+ and CD8+ T cell responses.J Immunol. 2002 Nov 1;169(9):4778-87. doi: 10.4049/jimmunol.169.9.4778. J Immunol. 2002. PMID: 12391187
-
Simian immunodeficiency virus (SIV) gag DNA-vaccinated rhesus monkeys develop secondary cytotoxic T-lymphocyte responses and control viral replication after pathogenic SIV infection.J Virol. 2000 Aug;74(16):7485-95. doi: 10.1128/jvi.74.16.7485-7495.2000. J Virol. 2000. PMID: 10906202 Free PMC article.
-
Potentiation of simian immunodeficiency virus (SIV)-specific CD4(+) and CD8(+) T cell responses by a DNA-SIV and NYVAC-SIV prime/boost regimen.J Immunol. 2001 Dec 15;167(12):7180-91. doi: 10.4049/jimmunol.167.12.7180. J Immunol. 2001. PMID: 11739541
-
CD4+ T cell responses to simian immunodeficiency virus.Curr Top Microbiol Immunol. 1994;188:161-73. doi: 10.1007/978-3-642-78536-8_9. Curr Top Microbiol Immunol. 1994. PMID: 7924425 Review. No abstract available.
Cited by
-
Structure and immunogenicity of alternative forms of the simian immunodeficiency virus gag protein expressed using Venezuelan equine encephalitis virus replicon particles.Virology. 2007 Jun 5;362(2):362-73. doi: 10.1016/j.virol.2006.12.029. Epub 2007 Feb 1. Virology. 2007. PMID: 17275057 Free PMC article.
-
Intranasal immunization with chitosan/pCAGGS-flaA nanoparticles inhibits Campylobacter jejuni in a White Leghorn model.J Biomed Biotechnol. 2010;2010:589476. doi: 10.1155/2010/589476. Epub 2010 Aug 16. J Biomed Biotechnol. 2010. PMID: 20936115 Free PMC article.
-
A naturally occurring deletion in its NS gene contributes to the attenuation of an H5N1 swine influenza virus in chickens.J Virol. 2008 Jan;82(1):220-8. doi: 10.1128/JVI.00978-07. Epub 2007 Oct 17. J Virol. 2008. PMID: 17942562 Free PMC article.
-
The immune response to a vesicular stomatitis virus vaccine vector is independent of particulate antigen secretion and protein turnover rate.J Virol. 2012 Apr;86(8):4253-61. doi: 10.1128/JVI.05991-11. Epub 2012 Feb 15. J Virol. 2012. PMID: 22345454 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials